Citation Impact
Citing Papers
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
Regulated Expression of a Tumor-Associated Antigen Reveals Multiple Levels of T-Cell Tolerance in a Mouse Model of Lung Cancer
2008
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials
2007
Selective cancer-germline gene expression in pediatric brain tumors
2008
Immunity, ageing and cancer
2008
Engineering precision nanoparticles for drug delivery
2020 Standout
High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
2014
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
CD44: From adhesion molecules to signalling regulators
2003 Standout
Cancer/testis (CT) antigens: Potential targets for immunotherapy
2009
Establishing the Diagnosis of Lung Cancer
2013 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
About human tumor antigens to be used in immunotherapy
2008
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Cancer drug resistance: an evolving paradigm
2013 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Specificity in cancer immunotherapy
2008
Cancer immunotherapy via dendritic cells
2012 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Complex networks orchestrate epithelial–mesenchymal transitions
2006 Standout
Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?
2013
CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells
2001
Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate‐tumour‐associated antigens
2006
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
The Systemic Progression of Human Cancer: A Focus on the Individual Disseminated Cancer Cell—The Unit of Selection
2003
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Myeloid Clusters Are Associated with a Pro-Metastatic Environment and Poor Prognosis in Smoking-Related Early Stage Non-Small Cell Lung Cancer
2013
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Oesophageal carcinoma
2013 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition
2005
Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology
2014
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Immune targets and neoantigens for cancer immunotherapy and precision medicine
2016
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
2004
B Lymphocytes and Cancer: A Love–Hate Relationship
2016
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
2018
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Review: Biological relevance of disseminated tumor cells in cancer patients
2008
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
2022
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Correlation between the Size of the Solid Component on Thin-Section CT and the Invasive Component on Pathology in Small Lung Adenocarcinomas Manifesting as Ground-Glass Nodules
2013
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
HLA-Binding Properties of Tumor Neoepitopes in Humans
2014
Evolution of the immune system in humans from infancy to old age
2015 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Molecular Staging of Lymph Nodes from Patients with Esophageal Adenocarcinoma
2005
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
2010
Translational nanoparticle engineering for cancer vaccines
2017
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
2015
Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma
2011
Computational selection of antibody-drug conjugate targets for breast cancer
2015
Works of Tomoko So being referenced
Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC
2010
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules
2006
Successful Induction of Tumor‐specific Cytotoxic T Lymphocytes from Patients with Non‐small Cell Lung Cancer Using CD80‐transfected Autologous Tumor Cells
2001
Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer
2009
Limited pulmonary resection for peripheral small-sized adenocarcinoma of the lung
2010
Prognostic implications of human leukocyte antigen class I expression in patients who underwent surgical resection for non–small-cell lung cancer
2012
Clinical Significance of IGF1R Expression in Non–Small-Cell Lung Cancer
2012
A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma
2005
Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growth.
2006
Identification of a New Cancer/Germline Gene,KK-LC-1, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung Adenocarcinoma
2006
Simultaneous Cellular and Humoral Immune Response against Mutated p53 in a Patient with Lung Cancer
2004
Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer.
2002
Induction of tumor-specific cytotoxic T lymphocytes from regional lymph node lymphocytes of human breast cancer
1998
Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase.
2001
Prognostic Impact of Micrometastatic Tumor Cells in the Lymph Nodes and Bone Marrow of Patients With Completely Resected Stage I Non–Small-Cell Lung Cancer
2002